Cargando…
EMSY links breast cancer gene 2 to the 'Royal Family'
Although the role of the breast cancer gene 2 (BRCA2) tumor suppressor gene is well established in inherited breast and ovarian carcinomas, its involvement in sporadic disease is still uncertain. The recent identification of a novel BRCA2 binding protein, EMSY, as a putative oncogene implicates the...
Autores principales: | Yao, Jun, Polyak, Kornelia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549177/ https://www.ncbi.nlm.nih.gov/pubmed/15318925 http://dx.doi.org/10.1186/bcr916 |
Ejemplares similares
-
Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families
por: Määttä, Kirsi M., et al.
Publicado: (2017) -
The EMSY threonine 207 phospho-site is required for EMSY-driven suppression of DNA damage repair
por: Jelinic, Petar, et al.
Publicado: (2017) -
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2018) -
The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31
por: Viré, Emmanuelle, et al.
Publicado: (2014) -
A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer
por: Mulrane, Laoighse, et al.
Publicado: (2014)